News from Asia


Mesoblast’s heart treatment MPCs patented in Japan

March 30, 2015  |   News

This patent provides commercial rights in Japan through to at least 29 March 2024, with potential for patent term extension for up to five years


Bayer receives approval for Gadovist injection in Japan

March 30, 2015  |   News

Gadovist is the first high concentration/high relaxivity gadolinium-based contrast agent to be approved in Japan


Chugai, Gilead get Japanese approval for additional indication of antiviral drug Copegus

March 30, 2015  |   News

Chugai claims that the combination therapy of Copegus and Sovaldi is the first all-oral treatment regimen for patients with serogroup 2 hepatitis C virus in Japan

More News from Asia

Survey Box

Medical Tourism

Will rise in medical tourism lead to more innovations in healthcare?

Send this article by email